196 related articles for article (PubMed ID: 33640649)
1. Response to letter: A decision for life - Treatment decisions in newly diagnosed families with spinal muscular atrophy.
Kirschner J; Butoianu N; Goemans N; Haberlova J; Kostera-Pruszczyk A; Mercuri E; van der Pol WL; Quijano-Roy S; Sejersen T; Tizzano EF; Ziegler A; Servais L; Muntoni F
Eur J Paediatr Neurol; 2021 Jan; 30():103-104. PubMed ID: 33640649
[No Abstract] [Full Text] [Related]
2. [Werdnig-Hoffmann amyotrophy in a 7-month-old child].
Kutafin IuF; Osipov SM
Pediatriia; 1990; (4):91-3. PubMed ID: 2371136
[No Abstract] [Full Text] [Related]
3. Statistical considerations in the study of spinal muscular atrophy. Dallas-Cincinnati-Newington Spinal Muscular Atrophy (DCN-SMA) Study Group.
Buncher CR; Samaha F; Iannaccone ST; Russman BS; Cook JD; White M; McLaughlin C
Muscle Nerve; 1990; 13 Suppl():S45-8. PubMed ID: 2233886
[No Abstract] [Full Text] [Related]
4. [Infantile spinal muscular atrophy. Description of 2 cases of Werdnig-Hoffmann disease].
Priora U; Quaglia P; Vivalda M; Giachino-Amistà MT; Domeneghetti G; Sardi R
Minerva Pediatr; 1987 Sep; 39(17-18):709-14. PubMed ID: 3437861
[No Abstract] [Full Text] [Related]
5. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
Febrer A; Rodriguez N; Alias L; Tizzano E
J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
[TBL] [Abstract][Full Text] [Related]
6. Managing pregnancy in a spinal muscular atrophy type III patient in Indonesia: a case report.
Setyaningrum CTS; Harahap ISK; Nurputra DK; Rachman IT; Harahap NIF
J Med Case Rep; 2022 Jan; 16(1):14. PubMed ID: 35033190
[TBL] [Abstract][Full Text] [Related]
7. Spinal and bulbar muscular atrophy without tongue atrophy.
Sugawara M; Kato K; Watanabe S; Toyoshima I
Eur Neurol; 2001; 45(3):185-6. PubMed ID: 11306865
[No Abstract] [Full Text] [Related]
8. Spinal muscular atrophy: some easy clues to diagnosis.
Gupta PC; Ahuja B; Dhamija K; Mullick DN
Indian Pediatr; 1989 Oct; 26(10):977-80. PubMed ID: 2630460
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of ECG in the early diagnosis of infantile spinal muscular dystrophy].
Carboni P; Porro G
Minerva Pediatr; 1988 Jun; 40(6):321-5. PubMed ID: 3185431
[No Abstract] [Full Text] [Related]
10. Methodological challenges in measuring meaningful change in individuals with spinal muscular atrophy.
Oskoui M; Potter BK
Muscle Nerve; 2021 Dec; 64(6):639-640. PubMed ID: 34687231
[No Abstract] [Full Text] [Related]
11. Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian Perspective.
Oskoui M; Gonorazky H; McMillan HJ; Dowling JJ; Amin R; Gagnon C; Selby K
Can J Neurol Sci; 2022 May; 49(3):398-401. PubMed ID: 34082851
[No Abstract] [Full Text] [Related]
12. Paradigm shift in the era of disease-modifying therapies for Spinal Muscular Atrophy type 1: respiratory challenges and opportunities.
Xiao L; Chiang J; Amin R
Sleep Med; 2021 Oct; 86():113-115. PubMed ID: 34253462
[No Abstract] [Full Text] [Related]
13. Atrial Septal Defect, Neuromuscular Junction and Skeletal Abnormalities in Spinal Muscular Atrophy Type III.
Luan XH; Liu J
Chin Med J (Engl); 2017 Oct; 130(19):2382-2383. PubMed ID: 28937047
[No Abstract] [Full Text] [Related]
14. Therapy and rehabilitation of the floppy infant.
Eng GD
R I Med J (1976); 1989 Oct; 72(10):367-70. PubMed ID: 2595191
[No Abstract] [Full Text] [Related]
15. A Decision for Life - Treatment decisions in newly diagnosed families with spinal muscular atrophy (SMA).
Gusset N; Erbas Y; Germanenko O; Rucinski K; Stumpe E; de Lemus M
Eur J Paediatr Neurol; 2021 Jan; 30():105-107. PubMed ID: 33353801
[No Abstract] [Full Text] [Related]
16. Effect on maximal mouth opening in children with spinal muscular atrophy treated with onasemnogene abeparvovec.
Beri N; Kapoor L; Parashar D; Mundada V
Arch Dis Child; 2023 Oct; 108(10):866-867. PubMed ID: 37553206
[No Abstract] [Full Text] [Related]
17. It's time to measure disability in spinal muscular atrophy.
Trabacca A; Ferrante C; De Rinaldis M
Acta Myol; 2022 Jun; 41(2):57-58. PubMed ID: 35832503
[No Abstract] [Full Text] [Related]
18. Gene replacement therapy for spinal muscular atrophy unmasking occult hepatitis C in a pediatric patient.
Lakhotia A; Turek G; Green J; Khan M
Muscle Nerve; 2022 Jan; 65(1):E2-E3. PubMed ID: 34644404
[No Abstract] [Full Text] [Related]
19. Newborn infant screening for spinal muscular atrophy: Chances and challenges.
Mueller-Felber W
Dev Med Child Neurol; 2022 May; 64(5):535. PubMed ID: 35156200
[No Abstract] [Full Text] [Related]
20. Minimal detectable change and minimal clinically important difference in spinal muscular atrophy patients.
Vázquez-Costa JF; Hervás D
Eur J Neurol; 2021 Jun; 28(6):e40-e41. PubMed ID: 33604967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
